Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06162195 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06162195 · ClinicalTrials.gov record · last posted 2026-08-13

The ACTIVE Trial: A Prospective Randomised Control Trial Of The H1 Implant Versus Total Hip Replacement

Study acronym: ACTIVE
StatusRecruiting
PhaseNot applicable
Started2026-07-21
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The goal of this randomised controlled trial is to compare the success of two types of hip replacement in patients with hip arthritis. The main question it aims to answer is whether a new type of hip replacement (called a hip resurfacing) can be as successful as an existing hip replacement (called a total hip replacement). Patients will be given either the new hip resurfacing or the existing total hip replacement and researchers will compare their function, complication rate and physical activity.

Protocol amendment history 4 changes detected by DataLookout

2026-08-14
Recruitment opened
2026-08-14
Trial sites expanded: 0 → 3 locations
2026-08-14
Primary completion pushed: 2027-04 → 2028-12-31
2026-08-14
Completion pushed: 2035-04 → 2036-12-31
Trial Details
NCT Number NCT06162195
Lead Sponsor Embody Orthopaedic Limited
Collaborators: Imperial College London, National Institute for Health Research, United Kingdom
Conditions Osteoarthritis, Hip, Inflammatory Arthritis
Enrollment 200 participants
Start Date 2026-07-21
Primary Completion 2028-12-31 (estimated)
Study Completion 2036-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-13